Should persons with acute myeloid leukemia (AML) in 1st histological complete remission who are measurable residual disease (MRD) test positive receive an allotransplant?

Venditti, A., Peter Gale, R., Buccisano, F., & Ossenkoppele, G. (2020, April 1). Should persons with acute myeloid leukemia (AML) in 1st histological complete remission who are measurable residual disease (MRD) test positive receive an allotransplant? Leukemia. Springer Nature. https://doi.org/10.1038/s41375-020-0780-6